• Wion
  • /World
  • /Study: Sinopharm vaccine jab weak against Omicron variant of the COVID-19 - World News

Study: Sinopharm vaccine jab weak against Omicron variant of the COVID-19

Study: Sinopharm vaccine jab weak against Omicron variant of the COVID-19
According to a recent Chinese study involving 292 samples, the Sinopharm vaccine jab is weak against the Omicron variant of COVID-19.